Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Dec 10, 2025

Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 8, 2025

Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seeking Alpha • Dec 3, 2025

Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 2, 2025

4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.

Zacks Investment Research • Dec 1, 2025

Potentially 12%-15% Consistent Income: Monthly Options Series (December 2025)

Selling options can generate 12-15% annual income but requires discipline, risk management, and due diligence. We explain why selling cash-covered puts and covered calls is a relatively safe choice for earning a high income. We will discuss how to formulate a sustainable and repeatable income strategy for options.

Seeking Alpha • Nov 30, 2025

Best Dividend Aristocrats For December 2025

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is slightly below 2024 levels.

Seeking Alpha • Nov 29, 2025

Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • Nov 27, 2025

Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Nov 27, 2025

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Nov 26, 2025